Despite the fact that MRI has evolved to become the standard method for diagnosis and
monitoring of patients with brain tumours, conventional MRI sequences have two key …

A recent meeting was held on March 22, 2019, among the FDA, clinical scientists,
pharmaceutical and biotech companies, clinical trials cooperative groups, and patient …

Brain metastases (BM) from extracranial cancer are associated with significant morbidity and
mortality. Effective local treatment options are stereotactic radiotherapy, including …

Since its introduction in the early nineties as a promising functional imaging technique in the
management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has …

Simple Summary Positron emission tomography (PET) is a functional imaging technique
which plays an increasingly important role in the management of brain tumors. Owing …

The advent of immunotherapy using immune checkpoint inhibitors (ICIs) and targeted
therapy (TT) has dramatically improved the prognosis of various cancer types. However …

The imaging and clinical management of patients with brain tumor continue to evolve over
time and now heavily rely on physiologic imaging in addition to high-resolution structural …

Over the past decades, a variety of PET tracers have been used for the evaluation of patients
with brain tumors. For clinical routine, the most important clinical indications for PET imaging …

Magnetic resonance imaging (MRI) is the cornerstone for evaluating patients with brain
masses such as primary and metastatic tumors. Important challenges in effectively detecting …

Radiation therapy is an important modality used in the treatment of patients with brain
metastatic disease and malignant gliomas. Post-treatment surveillance often involves serial …